Oscar Health, Inc. financial data

Symbol
OSCR on NYSE
Location
75 Varick Street, 5 Th Floor, New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 89.3 % -13.5%
Debt-to-equity 403 % +24.9%
Return On Equity -21.5 % -870%
Return On Assets -4.28 % -747%
Operating Margin -1.86 % -358%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 3.1B USD +107%
Weighted Average Number of Shares Outstanding, Basic 259M shares +6.65%
Weighted Average Number of Shares Outstanding, Diluted 259M shares +6.65%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 11.3B USD +37.4%
Revenue from Contract with Customer, Excluding Assessed Tax 24.4M USD +13.7%
General and Administrative Expense 30.2M USD -1.34%
Operating Income (Loss) -210M USD -453%
Nonoperating Income (Expense) -3.24M USD -469%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -238M USD -753%
Income Tax Expense (Benefit) 5.45M USD -21.1%
Net Income (Loss) Attributable to Parent -244M USD -943%
Earnings Per Share, Basic -1 USD/shares -1009%
Earnings Per Share, Diluted -1 USD/shares -1150%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.15B USD +78.2%
Other Assets, Current 28.6M USD +38.4%
Assets, Current 3.76B USD +58.9%
Property, Plant and Equipment, Net 83.4M USD +25.2%
Operating Lease, Right-of-Use Asset 57.2M USD -9.1%
Other Assets, Noncurrent 121M USD +43%
Assets 5.75B USD +28.2%
Liabilities, Current 3.98B USD +34.6%
Operating Lease, Liability, Noncurrent 60.7M USD -9.21%
Other Liabilities, Noncurrent 55.8M USD -12.2%
Liabilities 4.72B USD +42.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 16.4M USD -37.1%
Retained Earnings (Accumulated Deficit) -2.94B USD -9.05%
Stockholders' Equity Attributable to Parent 1.02B USD -11.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.03B USD -11.9%
Liabilities and Equity 5.75B USD +28.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 879M USD +38.5%
Net Cash Provided by (Used in) Financing Activities 4.87M USD -82.2%
Net Cash Provided by (Used in) Investing Activities -174M USD +42%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 709M USD +96.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.17B USD +76.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 154K USD -98.6%
Deferred Tax Assets, Valuation Allowance 591M USD -0.18%
Deferred Tax Assets, Gross 605M USD +0.68%
Operating Lease, Liability 74.2M USD -8.37%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -254M USD -527%
Lessee, Operating Lease, Liability, to be Paid 102M USD -12.8%
Property, Plant and Equipment, Gross 181M USD +20.6%
Operating Lease, Liability, Current 13.5M USD -4.42%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.4M USD +14.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 13.5M USD -4.42%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Deferred Income Tax Expense (Benefit) 36K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 28.2M USD -22.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 17.1M USD +3.98%
Deferred Tax Assets, Operating Loss Carryforwards 525M USD -4.21%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 82.5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 17.2M USD +0.4%
Additional Paid in Capital 3.95B USD +3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 6.73M USD -13.8%
Deferred Tax Assets, Net of Valuation Allowance 14.1M USD +57.4%
Interest Expense 24.4M USD -0.69%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%